<DOC>
	<DOCNO>NCT01697644</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial ass compare efficacy safety two dose level somatropin long period ( till final height reach ) . This trial extension trial GHRETARD/BDP/14/NL ( 2-year initial trial ) GHRETARD/BPD/20/NL ( 2-year extension trial ) .</brief_summary>
	<brief_title>Growth Hormone Treatment Children Diagnosed Intrauterine Growth Retardation</brief_title>
	<detailed_description />
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Completion GHRETARD/BPD/20/NL trial Written inform consent child and/or parents/guardians continuation extension trial</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>